ID: ALA5270364

Max Phase: Preclinical

Molecular Formula: C16H19N3O

Molecular Weight: 269.35

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)n(C2CCNCC2)nc1-c1ccccc1

Standard InChI:  InChI=1S/C16H19N3O/c1-12-11-15(20)19(14-7-9-17-10-8-14)18-16(12)13-5-3-2-4-6-13/h2-6,11,14,17H,7-10H2,1H3

Standard InChI Key:  TWZULJZXADJJPI-UHFFFAOYSA-N

Associated Targets(Human)

NSD3 Tchem Histone-lysine N-methyltransferase NSD3 (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 269.35Molecular Weight (Monoisotopic): 269.1528AlogP: 2.14#Rotatable Bonds: 2
Polar Surface Area: 46.92Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.02CX LogP: 1.62CX LogD: -0.91
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.91Np Likeness Score: -0.78

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source